Clinical Scorecard: Kidney Testing Gets Under the Skin

At a Glance

Key Highlights

• Microneedle patch measures kidney injury biomarker in interstitial fluid.
• Neutrophil gelatinase-associated lipocalin increases before conventional markers.
• Patch remains functional after high-temperature exposure.
• Detection limits: 9 pg/mL in humans, 16 pg/mL in mice.
• Study highlights need for sample-specific reference ranges.

Guideline-Based Recommendations

Diagnosis

• Further studies needed to define clinically actionable interstitial fluid thresholds.
• Assess diagnostic performance in patients.

Management

• Multiplexed measurement of additional kidney biomarkers may improve specificity.

Monitoring & Follow-up

• Monitor interstitial fluid neutrophil gelatinase-associated lipocalin levels.

Risks

• Concentration affected by inflammation and other conditions.

Patient & Prescribing Data

Not tested in patients with kidney disease.

Potential for minimally invasive testing in kidney injury detection.

Clinical Best Practices

• Consider interstitial fluid as an alternative matrix for kidney biomarker testing.
• Ensure proper calibration and imaging post-patch removal.

Related Resources & Content

• Advanced Materials Study